Avantor, Inc., a leading global provider of mission-critical products and services, is headquartered in the United States. Founded in 1904, the company has established a strong presence in the life sciences and advanced technologies sectors, serving customers across various industries, including pharmaceuticals, biotechnology, and education. With a diverse portfolio that includes high-quality laboratory supplies, chemicals, and custom manufacturing solutions, Avantor distinguishes itself through its commitment to innovation and customer-centric approach. The company has achieved significant milestones, including strategic acquisitions that have expanded its operational footprint in key regions worldwide. Recognised for its market leadership, Avantor continues to drive advancements in scientific research and development, making it a trusted partner for organisations seeking reliable and efficient solutions in the ever-evolving landscape of science and technology.
How does Avantor's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Avantor's score of 56 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Avantor, headquartered in the US, reported total greenhouse gas emissions of approximately 4,799,681,000 kg CO2e. This figure includes 39,502,000 kg CO2e from Scope 1 (direct emissions) and 34,996,000 kg CO2e from Scope 2 (indirect emissions). The majority of emissions stem from Scope 3, amounting to about 4,759,681,000 kg CO2e, which encompasses various categories such as the use of sold products and purchased goods and services. Avantor has set ambitious climate commitments, aiming to reduce its absolute Scope 1 and 2 emissions by 50% by 2030, using a 2020 baseline. This target is part of their broader sustainability strategy, which also includes a commitment to reduce Scope 3 emissions by 25% within the same timeframe. Additionally, they have announced a near-term goal to cut Scope 1 and 2 emissions by 15% by 2025 from a 2019 baseline. These targets are aligned with the Science Based Targets initiative (SBTi) and reflect Avantor's commitment to addressing climate change within the pharmaceuticals, biotechnology, and life sciences sector. The company is actively working towards these goals, demonstrating a proactive approach to sustainability and carbon footprint reduction.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 27,871,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 38,194,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | 0,000,000,000 | - | - | - | 0,000,000,000 |
Avantor's Scope 3 emissions, which increased by 1% last year and increased by approximately 1% since 2020, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Use of Sold Products" being the largest emissions source at 58% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Avantor has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Common questions about Avantor's sustainability data and climate commitments